Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to life with EUPATI


Published on

"Patient involvement in medicines R&D: Bringing to life with EUPATI", presented by Jan Geissler, EUPATI Director, at the EUPATI 2013 Conference on 19 April 2013

Published in: Health & Medicine, Spiritual
  • Be the first to comment

  • Be the first to like this

EUPATI 2013 Conference: Patient involvement in medicines R&D: Bringing to life with EUPATI

  1. 1. Jan Geissler, EUPATI DirectorPatient involvement inmedicines R&D:Bringing to life with EUPATIThe project is receiving support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115334, resources of which are composedof financial contribution from the European Unions Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.
  2. 2. PublicResearch EthicsCommitteesCompetentauthoritiesPolicy makersHTA agencies& committeesResearch subjectInfo providerAdvisorReviewerCo-researcherDriving forceClinicalResearchFor patient-centric medicines R&D, weneed more trained patient advocates
  3. 3. EUPATI: A paradigm shift in empoweringpatients on medicines R&D Launched Feb 2012, runs for 5 years,30 consortium members,PPP of EU Commission and EFPIA will develop and disseminateobjective, credible, correct knowledgeabout medicines R&D “end to end” will build competencies& expert capacity among patients& public will facilitate patient involvement in R&Dto support industry, academia, authoritiesand ethics committees
  4. 4. EUPATI Internet LibraryEUPATI Educational ToolboxEUPATI Training ProgrammeTo bring this to life, EUPATI developseducation targeted at different levels100“expert”patientadvocates12.000patientadvocates100.000individuals
  5. 5.  Leading pan-EU patient umbrellagroups. EPF coordinates. Strong impetus from key academicpartners and research organisations Industry expertise in medicines R&D,IT, capacity building Advisory bodies & codes committed toensure independence and goodgovernance• EMA, Swissmedic, MHRA, BfArM• Bioethics, genetics, HTA, economics, evidencebased med.,patient advocacy• Ethics PanelWorking in partnershipwith strong governance
  6. 6. Coordination& CommunicationEUPATI Network& MeetingsNeeds, focus groups,literature reviewContent Development& Translationse-Learning& content platformCourse deployment,National PlatformsSustainability & GuidanceBringing to life: Our work packages
  7. 7. EUPATI National Platforms:Partnership on the country levelEUPATI National Platforms will... make sure EUPATI understands educationalneeds in R&D on national levelwhen developing content disseminate EUPATI’s existing training material andinformation on the national level To raise public interest about EUPATI in 12 countries To identify training faculty, logistics and financialsupport on the national levelATBECHDEESFRITIELUXMTPLUK
  8. 8. 8There are still too many empty seatsin medicines R&D.Join us to bring our vision to life.
  9. 9. Working in partnershipto empower patientson medicines R&D.Web:www.patientsacademy.euTwitter: @eupatientsas well as: